US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insight Molecular Diagnostics Inc.

2.58

-0.0599-2.27%

Volume:16.26K

Turnover:42.54K

Market Cap:73.79M

PE:-0.77

High:2.69

Open:2.63

Low:2.58

Close:2.64

52wk High:4.75

52wk Low:1.92

Shares:28.60M

Float Shares:7.76M

Volume Ratio:2.89

T/O Rate:0.21%

Dividend:0.00

Dividend Rate:0.04%

EPS(TTM):-3.3429

EPS(LYR):-4.6612

ROE:-428.96%

ROA:-22.17%

PB:7.22

PE(LYR):-0.55

Loading ...

Overview Company News Filings

Insight Molecular Diagnostics Inc expected to post a loss of 23 cents a share - Earnings Preview

IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients

Insight Molecular Diagnostics Inc. Conducted Annual Shareholders Meeting Virtually

Insight Molecular Diagnostics (IMDX) Gets a Buy from Lake Street

BRIEF-iMDx Reports Strong Head-To-Head Data In Kidney Transplant Rejection Testing

Insight Molecular Diagnostics announces results from test kit technology study

Lake Street Keeps Their Buy Rating on OncoCyte (OCX)

BRIEF-Oncocyte Changes Name To Insight Molecular Diagnostics

OncoCyte Corporation Relocates Headquarters to Nashville, Rebrands as Insight Molecular Diagnostics

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IMDX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMDX\",,,,,undefined,":{"symbol":"IMDX","market":"US","secType":"STK","nameCN":"Insight Molecular Diagnostics Inc.","latestPrice":2.5801,"timestamp":1754664448092,"preClose":2.64,"halted":0,"volume":16263,"delay":0,"floatShares":7755045,"shares":28599285,"eps":-3.342915,"marketStatus":"Trading","change":-0.0599,"latestTime":"08-08 10:52:41 EDT","open":2.63,"high":2.685,"low":2.5801,"amount":42540.0447069,"amplitude":0.039735,"askPrice":2.65,"askSize":1,"bidPrice":2.56,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-3.342915,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1754683200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":2.64,"dividendRate":0.000388,"postHourTrading":{"tag":"盘后","latestPrice":2.58,"preClose":2.625,"latestTime":"17:57 EDT","volume":3314,"amount":8554.255,"timestamp":1754603844867},"volumeRatio":2.891979},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMDX\",,,,,undefined,":{"symbol":"IMDX","floatShares":7755045,"roa":"-22.17%","roe":"-428.96%","lyrEps":-4.661158,"volumeRatio":2.891979,"shares":28599285,"dividePrice":0.001,"high":2.685,"amplitude":0.039735,"preClose":2.64,"low":2.5801,"week52Low":1.922,"pbRate":"7.22","psRate":"19.20","week52High":4.75,"institutionHeld":0,"latestPrice":2.5801,"committee":0.99005,"eps":-3.342915,"divideRate":0.000388,"volume":16263,"delay":0,"ttmEps":-3.342915,"open":2.63,"prevYearClose":2.38,"prevWeekClose":2.56,"prevMonthClose":2.52,"prevQuarterClose":3.02,"fiveDayClose":2.56,"twentyDayClose":2.86,"sixtyDayClose":2.77,"earningDate":1754841600000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMDX\",params:#limit:5,,,undefined,":[{"date":"2025-08-11","symbol":"IMDX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":null,"defaultRemindTime":1754942400000,"name":null,"time":"Post Market","dateTimestamp":1754884800000,"actualEps":null},{"market":"US","date":"2025-05-12","symbol":"IMDX","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2025-03-24","symbol":"IMDX","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742788800000,"reportTimeType":"post","actualEps":0.48},{"market":"US","date":"2024-11-12","symbol":"IMDX","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.98},{"market":"US","date":"2024-08-08","symbol":"IMDX","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-0.36}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMDX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMDX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1743220800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMDX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMDX","date":"2025-08-07","current":-1.302089,"percent":0.909091,"low":-2.083343,"twenty":-1.517302,"median":-1.411416,"eighty":-1.36397,"high":-1.238213,"avg":-1.460044,"sd":0.162149,"marketCap":75788105},"quantilePoints":[{"date":"2025-06-20","current":-1.55268,"twenty":-1.55268,"median":-1.55268,"eighty":-1.55268,"marketCap":90373740},{"date":"2025-06-27","current":-1.655864,"twenty":-1.798357,"median":-1.675518,"eighty":-1.638667,"marketCap":96379590},{"date":"2025-07-03","current":-1.40036,"twenty":-1.71581,"median":-1.6055,"eighty":-1.491752,"marketCap":81507962},{"date":"2025-07-11","current":-1.420014,"twenty":-1.663726,"median":-1.493717,"eighty":-1.427876,"marketCap":82651933},{"date":"2025-07-18","current":-1.390533,"twenty":-1.642106,"median":-1.471607,"eighty":-1.399377,"marketCap":80935976},{"date":"2025-07-25","current":-1.454409,"twenty":-1.585601,"median":-1.459323,"eighty":-1.399377,"marketCap":84653883},{"date":"2025-08-01","current":-1.238213,"twenty":-1.556611,"median":-1.424927,"eighty":-1.390533,"marketCap":72070198},{"date":"2025-08-07","current":-1.302089,"twenty":-1.517302,"median":-1.411416,"eighty":-1.36397,"marketCap":75788105}],"updateTime":1754653128353},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMDX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2556634385","title":"Insight Molecular Diagnostics Inc  expected to post a loss of 23 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2556634385","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556634385?lang=en_us&edition=fundamental","pubTime":"2025-08-04 19:06","pubTimestamp":1754305566,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics Inc  expected to post a loss of23cents a share - Earnings Preview Insight Molecular Diagnostics Inc IMDX.OQ IMDX.O is expected to  show a rise in quarterly revenue when i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nL8N3TW0MN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMDX","MDIT"],"gpt_icon":0},{"id":"2555205020","title":"IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2555205020","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555205020?lang=en_us&edition=fundamental","pubTime":"2025-07-31 04:05","pubTimestamp":1753905900,"startTime":"0","endTime":"0","summary":"iMDx first dd-PCR assay to combine relative and absolute measurements of dd-cfDNA into single combined scoreData show significantly improved positive predictive value (PPV) for graft rejection, which ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/30/3124422/0/en/IMDX-World-Transplant-Congress-Late-Breaking-Data-Potentially-Sets-New-Bar-for-Predicting-Graft-Rejection-in-Kidney-Transplant-Patients.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGS","BK4179","BK4139","IMDX","KOL"],"gpt_icon":0},{"id":"2548485738","title":"Insight Molecular Diagnostics Inc. Conducted Annual Shareholders Meeting Virtually","url":"https://stock-news.laohu8.com/highlight/detail?id=2548485738","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548485738?lang=en_us&edition=fundamental","pubTime":"2025-07-03 05:02","pubTimestamp":1751490143,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics Inc. held its 2025 Annual Meeting of Shareholders on June 27, 2025, virtually via live webcast. The proposals presented included the election of four director nominees: Joshua Riggs, Andrew Arno, Andrew J. Last, and Louis E. Silverman, all of whom were elected. The appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for the year ending December 31, 2025, was ratified. An amendment to the Amended and Restated 2018 Equity Incentive Plan to increase the total number of shares authorized for issuance by 1,500,000, to a total of 3,800,000 shares, was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insight Molecular Diagnostics Inc. published the original content used","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nNDL9VwBln:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDIT","BK4139","IMDX","BK4082"],"gpt_icon":0},{"id":"2545096287","title":"Insight Molecular Diagnostics (IMDX) Gets a Buy from Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2545096287","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545096287?lang=en_us&edition=fundamental","pubTime":"2025-06-24 20:55","pubTimestamp":1750769730,"startTime":"0","endTime":"0","summary":"Lake Street analyst Thomas Flaten reiterated a Buy rating on Insight Molecular Diagnostics (IMDX – Research Report) today and set a price target of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/insight-molecular-diagnostics-imdx-gets-a-buy-from-lake-street-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/insight-molecular-diagnostics-imdx-gets-a-buy-from-lake-street-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INAQU","BK4139","IMDX"],"gpt_icon":0},{"id":"2545447075","title":"BRIEF-iMDx Reports Strong Head-To-Head Data In Kidney Transplant Rejection Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2545447075","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545447075?lang=en_us&edition=fundamental","pubTime":"2025-06-24 04:34","pubTimestamp":1750710874,"startTime":"0","endTime":"0","summary":"BRIEF-iMDx Reports Strong Head-To-Head Data In Kidney Transplant Rejection TestingJune 23 (Reuters) - Insight Molecular Diagnostics Inc IMDX.O:IMDX REPORTS STRONG HEAD-TO-HEAD DATA IN KIDNEY TRANSPLAN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nFWN3SQ0LD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BRIEF-iMDx Reports Strong Head-To-Head Data In Kidney Transplant Rejection Testing","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMDX"],"gpt_icon":0},{"id":"2545474534","title":"Insight Molecular Diagnostics announces results from test kit technology study","url":"https://stock-news.laohu8.com/highlight/detail?id=2545474534","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545474534?lang=en_us&edition=fundamental","pubTime":"2025-06-24 04:15","pubTimestamp":1750709743,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics (IMDX) announced results from a study evaluating its test kit technology in a head-to-head comparison with another co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/insight-molecular-diagnostics-announces-results-from-test-kit-technology-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/insight-molecular-diagnostics-announces-results-from-test-kit-technology-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INAQU","BK4139","IMDX"],"gpt_icon":0},{"id":"2544960526","title":"Lake Street Keeps Their Buy Rating on OncoCyte (OCX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2544960526","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544960526?lang=en_us&edition=fundamental","pubTime":"2025-06-17 20:55","pubTimestamp":1750164926,"startTime":"0","endTime":"0","summary":"In a report released today, Thomas Flaten from Lake Street maintained a Buy rating on OncoCyte (OCX – Research Report), with a price target of $8.0...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lake-street-keeps-their-buy-rating-on-oncocyte-ocx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lake-street-keeps-their-buy-rating-on-oncocyte-ocx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Lake Street Keeps Their Buy Rating on OncoCyte (OCX)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OCX","IMDX"],"gpt_icon":0},{"id":"2544643869","title":"BRIEF-Oncocyte Changes Name To Insight Molecular Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2544643869","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544643869?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:39","pubTimestamp":1750160350,"startTime":"0","endTime":"0","summary":"BRIEF-Oncocyte Changes Name To Insight Molecular Diagnostics June 17 (Reuters) - OncoCyte Corp OCX.O:ONCOCYTE CHANGES NAME TO INSIGHT MOLECULAR DIAGNOSTICS INC. (IMDX), MOVES HEADQUARTERS TO NASHVILLESource text: ID:nGNX6C2S0KFurther company coverage: OCX.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nFWN3SK0MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMDX","OCX"],"gpt_icon":0},{"id":"2544964892","title":"OncoCyte Corporation Relocates Headquarters to Nashville, Rebrands as Insight Molecular Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2544964892","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544964892?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:34","pubTimestamp":1750160055,"startTime":"0","endTime":"0","summary":"OncoCyte Corporation, now known as Insight Molecular Diagnostics Inc. , has announced the relocation of its headquarters from Irvine, California, to Nashville, Tennessee. This move aligns with the company's strategic shift towards precision biomarker-based testing in transplant and oncology care. The company's stock will trade under the new symbol \"IMDX\" on Nasdaq starting June 18, 2025. The relocation to Nashville, a hub for healthcare innovation, supports iMDx's transition from product development to commercialization, while maintaining its laboratory and R&D center in Gttingen, Germany.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OncoCyte Corporation published the original content used to generate this news brief via EDGAR, the E","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nNDLbjFJ26:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","MDIT","OCX","IMDX","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}]}}